To systematically evaluate the effectiveness and safety of secukinumab in the treatment of psoriatic arthritis (PA).
Relevant literature on the treatment of PA with secukinumab were searched in English databases (PubMed, MEDLINE, Embase, Cochrance Library) and the Chinese databases (CNKI, VIP, Wanfang), from January 2000 to December 2020. After quality evaluation of the literatures that met the inclusion criteria, the meta analysis was conducted with Revman 5.4 software.
A total of 5 randomized controlled studies involving 2 455 patients with PA were included for analysis. Meta analysis results showed that compared with the treatment of the placebo group, the treatment group with secukinumab significantly improved the patients' remission of American College of Rheumatology (ACR) by 20%[odds ratio (OR)=4.40, 95% confidence interval (CI)(3.79, 5.11), P<0.000 01], ACR50 [OR=5.84, 95%CI (4.82, 7.07), P<0.000 01], ACR70[OR=7.98, 95%CI (5.64, 11.27), P<0.000 01], psoriatic area and severity index (PASI) 75[OR=9.72, 95%CI (6.68, 14.14), P<0.000 01] and PASI90[OR=7.75, 95%CI (4.92, 12.22), P<0.000 01]. Compared with the 150 mg group, the ACR20 in 300 mg secukinumab group was significantly improved [OR=1.36, 95%CI (1.04, 1.76), P=0.02]. In terms of safety, there was no significant difference in the incidence of overall adverse events and serious adverse events between the secukinumab group and the placebo group (P>0.05). The incidence of candida infection and tumor in the secukinumab group was significantly higher than that in the placebo group [OR=2.29, 95%CI (1.18, 4.46), P=0.01, OR=3.38, 95%CI (1.20, 9.53), P=0.02].
The efficacy and safety of secukinumab in the treatment of PA skin lesions and joint lesions are reliable. However, since secukinumab has just been marketed in China, there is no long-term clinical research report, and a large number of clinical studies and further verification are needed in the future.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |